Key Insights The projected fair value for Utah Medical Products is US$64.17 based on 2 Stage Free Cash Flow to ...

Investing.com -- Vestas Wind Systems (CSE:VWS) received a double upgrade as Kepler Cheuvreux reversed its July 2025 “reduce” call and raised the stock to “buy,” citing a substantial reassessment of ...

Key Insights News' estimated fair value is US$30.98 based on 2 Stage Free Cash Flow to Equity Current share price ...

Vertiv's shares really began to pop in mid-2023, and they continued their outperformance into 2024. That's boosted the ...

Making moves in the stock market can be complicated. But as Warren Buffett points out, if you don’t want it to be this way, ...

Morningstar stock has declined despite continued revenue and operating income growth. Read more on what investors need to ...

Enterprise value (EV) is a measure of a company's total value--going beyond just equity. EV represents what it would cost to ...

The structural initiatives include a “forestry concierge” at Natural Resources Canada to help mills navigate loans and programs as well as an industry-led transformation task force to expand, ...

L'Oréal is approaching its intrinsic value, with recent results showing modest growth and resilience in a challenging luxury ...

Concurrent Technologies' (LON:CNC) stock is up by a considerable 36% over the past three months. Given that the ...

Super Micro Computer (NASDAQ:SMCI) has had a rough month with its share price down 36%. However, a closer look at ...

Pfizer possesses several qualities that make it attractive when market volatility is high. The stock has a low forward earnings multiple and a higher -- yet still attractive -- EV-to-EBITDA ratio.